Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for stroke prevention in non-valvular atrial fibrillation (China, Phase IV observational)
CTR20150672Phase 4Completed
- Sponsor
- ---
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in Atrial fibrillation (AFib), sponsored by ---. Started Apr 2016; status: completed.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on CTR20150672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150672.